Serge Petit

Title: The Innovations of Serge Petit

Introduction

Serge Petit is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of medical research, particularly in the development of treatments for colorectal cancer. With a total of 2 patents, his work has the potential to impact the lives of many patients.

Latest Patents

One of Serge Petit's latest patents involves the creation of anti-CK8 antibodies that are used for treating colorectal cancers. This invention focuses on antibodies specific to human CK8 and includes pharmaceutical compositions aimed at preventing and treating colorectal cancers. Additionally, it outlines methods for identifying colorectal cancers with invasive and/or metastatic phenotypes by detecting the cleavage of the C-terminal portion of human CK8 on the surface of tumor cells. Another significant patent involves new drugs comprising 2,3- or 3,4-diphenyl derivatives of γ-nitrile-esters. This patent claims a process for cyclization of these derivatives and describes new 2,3- and 3,4-diphenyl derivatives corresponding to specific formulae.

Career Highlights

Throughout his career, Serge Petit has worked with esteemed institutions such as Université Claude Bernard Lyon 1 and Hospices Civils De Lyon. His research has been pivotal in advancing the understanding and treatment of colorectal cancer.

Collaborations

Serge Petit has collaborated with notable colleagues, including Jean-Jacques Diaz and Jean-Xavier Roca-Martinez. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Serge Petit is a distinguished inventor whose work in the medical field has led to significant advancements in cancer treatment. His patents reflect a commitment to improving patient outcomes and enhancing the understanding of colorectal cancer.